Results 71 to 80 of about 396,740 (196)
Cellular and Molecular Biology of Esophageal Cancer
Esophageal cancers comprise cancers of different histological types with diverse cellular and molecular bases. The major histological types of esophageal cancers are squamous cell carcinoma and adenocarcinoma.
Lam, AKY, Alfred King-yin Lam
core +1 more source
Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma [PDF]
Esophageal adenocarcinoma is an increasingly common disease with a dismal 5-year survival rate of 10% to 15%. In the first systematic evaluation of the PD-1 pathway in esophageal adenocarcinoma, we identify expression of PD-L2 in cancer cells in 51.7% of
Goldberg, Michael S +11 more
core +1 more source
Log odds for esophageal adenocarcinoma among esophageal cancer over the study period (2002–2011).
Log odds for esophageal adenocarcinoma among esophageal cancer over the study period (2002–2011).
Xiaohong Li (71964) +11 more
core +1 more source
Nonsurgical Management of Esophageal Adenocarcinoma
The benefit of induction chemotherapy (IC) before chemoradiotherapy (CRT) for inoperable esophageal adenocarcinoma has not been established. To clarify toxicities and outcomes of combined modality treatment, we performed a retrospective review.Sixty-eight consecutive patients were identified. Fifty-one patients had CRT, 17 had radiotherapy (RT).
Gujral, D +6 more
openaire +3 more sources
L-Type Amino Acid Transporter-1 Overexpression and Melphalan Sensitivity in Barrett's Adenocarcinoma
The L-type amino acid transporter-1 (LAT-1) has been associated with tumor growth. Using cDNA microarrays, overexpression of LAT-1 was found in 87.5% (7/8) of esophageal adenocarcinomas relative to 12 Barrett's samples (33% metaplasia and 66% dysplasia ...
Jules Lin +9 more
doaj +1 more source
Introduction. The objective of this study was to evaluate Ki-67 antigen expression in patients with Barrett’s esophagus and esophageal adenocarcinoma and to assess its correlation with the metaplasia-esophageal adenocarcinoma progression. Methods.
Bernardo Silveira Volkweis +5 more
doaj +1 more source
Risk stratification for early esophageal adenocarcinoma: Analysis of lymphatic spread
Background. Knowledge of factors related to outcome is vital for the selection of therapeutic alternatives for patients with early (T1) esophageal adenocarcinoma.
Barbour, Andrew P. +7 more
core +1 more source
Background Cervical esophageal adenocarcinoma is a rare tumor often associated with Barrett’s esophagus, and its prevalence is lower than distal esophageal adenocarcinoma.
Ali Saeidpour parizi +6 more
doaj +1 more source
Esophageal Squamous Cell Cancer: Pathogenesis and Epidemiology
Esophageal cancer is a highly lethal disease. Despite an increasing incidence of adenocarcinoma in last decades, squamous cell carcinoma remains the predominant cell type worldwide. The majority of squamous cell cancers are from the East.
Law, S, Wong, C
core +1 more source
Thyroid metastasis from esophageal adenocarcinoma: a case report and literature review
Background The incidence of metastatic spread of gastrointestinal malignancies to the thyroid gland is relatively low and most of these malignancies originate from the colorectum.
Shinsei Yumoto +12 more
doaj +1 more source

